Cyclin D1–Cdk4 controls glucose metabolism independently of cell cycle progression
Open Access
- 25 May 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 510 (7506), 547-551
- https://doi.org/10.1038/nature13267
Abstract
Formation of an active cyclin D1–Cdk4 complex suppresses glucose metabolism independently of cell division. The mechanisms connecting insulin signalling and transcriptionally mediated suppression of gluconeogenic genes remain unclear. This study of insulin signalling in mice supports a regulatory model in which insulin facilitates the formation of an active cyclin D1–Cdk4 complex that subsequently suppresses gluconeogenesis, in part by decreasing PGC-1 activity through GCN5-mediated acetylation. Thus, insulin uses components of the cell-cycle machinery to control glucose homeostasis independently of cell division. Further studies of the metabolic functions of cell-cycle components in different tissues could provide candidate targets for drugs to treat metabolic diseases. Insulin constitutes a principal evolutionarily conserved hormonal axis for maintaining glucose homeostasis1,2,3; dysregulation of this axis causes diabetes2,4. PGC-1α (peroxisome-proliferator-activated receptor-γ coactivator-1α) links insulin signalling to the expression of glucose and lipid metabolic genes5,6,7. The histone acetyltransferase GCN5 (general control non-repressed protein 5) acetylates PGC-1α and suppresses its transcriptional activity, whereas sirtuin 1 deacetylates and activates PGC-1α8,9. Although insulin is a mitogenic signal in proliferative cells10,11, whether components of the cell cycle machinery contribute to its metabolic action is poorly understood. Here we report that in mice insulin activates cyclin D1–cyclin-dependent kinase 4 (Cdk4), which, in turn, increases GCN5 acetyltransferase activity and suppresses hepatic glucose production independently of cell cycle progression. Through a cell-based high-throughput chemical screen, we identify a Cdk4 inhibitor that potently decreases PGC-1α acetylation. Insulin/GSK-3β (glycogen synthase kinase 3-beta) signalling induces cyclin D1 protein stability by sequestering cyclin D1 in the nucleus. In parallel, dietary amino acids increase hepatic cyclin D1 messenger RNA transcripts. Activated cyclin D1–Cdk4 kinase phosphorylates and activates GCN5, which then acetylates and inhibits PGC-1α activity on gluconeogenic genes. Loss of hepatic cyclin D1 results in increased gluconeogenesis and hyperglycaemia. In diabetic models, cyclin D1–Cdk4 is chronically elevated and refractory to fasting/feeding transitions; nevertheless further activation of this kinase normalizes glycaemia. Our findings show that insulin uses components of the cell cycle machinery in post-mitotic cells to control glucose homeostasis independently of cell division.Keywords
This publication has 37 references indexed in Scilit:
- Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetesNature, 2012
- Dissociation of Inositol-requiring Enzyme (IRE1α)-mediated c-Jun N-terminal Kinase Activation from Hepatic Insulin Resistance in Conditional X-box-binding Protein-1 (XBP1) Knock-out MiceJournal of Biological Chemistry, 2012
- A Systematic Screen for CDK4/6 Substrates Links FOXM1 Phosphorylation to Senescence Suppression in Cancer CellsCancer Cell, 2011
- Dietary Leucine - An Environmental Modifier of Insulin Resistance Acting on Multiple Levels of MetabolismPLOS ONE, 2011
- Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1)British Journal of Cancer, 2011
- Cdc2-like Kinase 2 Is an Insulin-Regulated Suppressor of Hepatic GluconeogenesisCell Metabolism, 2010
- Sensitivity of Lipid Metabolism and Insulin Signaling to Genetic Alterations in Hepatic Peroxisome Proliferator–Activated Receptor-γ Coactivator-1α ExpressionDiabetes, 2009
- Cell cycle, CDKs and cancer: a changing paradigmNature Reviews Cancer, 2009
- Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2Nature, 2007
- Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1Proceedings of the National Academy of Sciences of the United States of America, 2007